These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 26781085)

  • 21. Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse.
    Wang HH; Dai YQ; Qiu W; Lu ZQ; Peng FH; Wang YG; Bao J; Li Y; Hu XQ
    J Clin Neurosci; 2011 Oct; 18(10):1313-7. PubMed ID: 21795048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single-cell analysis of cytokine production shows different immune profiles in multiple sclerosis patients with active or quiescent disease.
    Clerici M; Saresella M; Trabattoni D; Speciale L; Fossati S; Ruzzante S; Cavaretta R; Filippi M; Caputo D; Ferrante P
    J Neuroimmunol; 2001 Dec; 121(1-2):88-101. PubMed ID: 11730945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal single-cell cytokine responses reveal recurrent autoimmune myelin reactivity in relapsing--remitting multiple sclerosis patients.
    Moldovan IR; Rudick RA; Cotleur AC; Born SE; Lee JC; Karafa MT; Pelfrey CM
    Mult Scler; 2005 Jun; 11(3):251-60. PubMed ID: 15957503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
    Rostami A; Ciric B
    J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated frequencies of CD4(+) IL-21(+) T, CD4(+) IL-21R(+) T and IL-21(+) Th17 cells, and increased levels of IL-21 in bleomycin-induced mice may be associated with dermal and pulmonary inflammation and fibrosis.
    Lei L; He ZY; Zhao C; Sun XJ; Zhong XN
    Int J Rheum Dis; 2016 Apr; 19(4):392-404. PubMed ID: 25545680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Th22 cells are expanded in multiple sclerosis and are resistant to IFN-β.
    Rolla S; Bardina V; De Mercanti S; Quaglino P; De Palma R; Gned D; Brusa D; Durelli L; Novelli F; Clerico M
    J Leukoc Biol; 2014 Dec; 96(6):1155-64. PubMed ID: 25097195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytokine secretion pattern in treatment of lymphocytes of multiple sclerosis patients with fumaric acid esters.
    Zoghi S; Amirghofran Z; Nikseresht A; Ashjazadeh N; Kamali-Sarvestani E; Rezaei N
    Immunol Invest; 2011; 40(6):581-96. PubMed ID: 21510778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dysregulation of the IL-23/IL-17 axis and myeloid factors in secondary progressive MS.
    Huber AK; Wang L; Han P; Zhang X; Ekholm S; Srinivasan A; Irani DN; Segal BM
    Neurology; 2014 Oct; 83(17):1500-7. PubMed ID: 25253754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulatory Cell Populations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients: Effect of Disease Activity and Treatment Regimens.
    Rodi M; Dimisianos N; de Lastic AL; Sakellaraki P; Deraos G; Matsoukas J; Papathanasopoulos P; Mouzaki A
    Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27571060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glatiramer acetate (copolymer-1)-specific, human T cell lines: cytokine profile and suppression of T cell lines reactive against myelin basic protein.
    Dabbert D; Rösner S; Krämer M; Schöll U; Tumani H; Mäder M; Weber F
    Neurosci Lett; 2000 Aug; 289(3):205-8. PubMed ID: 10961665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokine phenotype of human autoreactive T cell clones specific for the immunodominant myelin basic protein peptide (83-99).
    Hemmer B; Vergelli M; Calabresi P; Huang T; McFarland HF; Martin R
    J Neurosci Res; 1996 Sep; 45(6):852-62. PubMed ID: 8892097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-7-enhanced T-cell response to myelin proteins in multiple sclerosis.
    Traggiai E; Biagioli T; Rosati E; Ballerini C; Mazzanti B; Ben Nun A; Massacesi L; Vergelli M
    J Neuroimmunol; 2001 Dec; 121(1-2):111-9. PubMed ID: 11730947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracellular cytokine profile in T-cell subsets of multiple sclerosis patients: different features in primary progressive disease.
    Killestein J; Den Drijver BF; Van der Graaff WL; Uitdehaag BM; Polman CH; Van Lier RA
    Mult Scler; 2001 Jun; 7(3):145-50. PubMed ID: 11475436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myelin oligodendrocyte glycoprotein revisited-sensitive detection of MOG-specific T-cells in multiple sclerosis.
    Bronge M; Ruhrmann S; Carvalho-Queiroz C; Nilsson OB; Kaiser A; Holmgren E; Macrini C; Winklmeier S; Meinl E; Brundin L; Khademi M; Olsson T; Gafvelin G; Grönlund H
    J Autoimmun; 2019 Aug; 102():38-49. PubMed ID: 31054941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol.
    Soldan SS; Alvarez Retuerto AI; Sicotte NL; Voskuhl RR
    J Immunol; 2003 Dec; 171(11):6267-74. PubMed ID: 14634144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b.
    Ochi H; Feng-Jun M; Osoegawa M; Minohara M; Murai H; Taniwaki T; Kira J
    J Neurol Sci; 2004 Jul; 222(1-2):65-73. PubMed ID: 15240198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-11 Induces Encephalitogenic Th17 Cells in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.
    Zhang X; Kiapour N; Kapoor S; Khan T; Thamilarasan M; Tao Y; Cohen S; Miller R; Sobel RA; Markovic-Plese S
    J Immunol; 2019 Sep; 203(5):1142-1150. PubMed ID: 31341075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased frequency of proinflammatory CD4 T cells and pathological levels of serum neurofilament light chain in adult drug-resistant epilepsy.
    Ouédraogo O; Rébillard RM; Jamann H; Mamane VH; Clénet ML; Daigneault A; Lahav B; Uphaus T; Steffen F; Bittner S; Zipp F; Bérubé A; Lapalme-Remis S; Cossette P; Nguyen DK; Arbour N; Keezer MR; Larochelle C
    Epilepsia; 2021 Jan; 62(1):176-189. PubMed ID: 33140401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoregulation and blocking antibodies induced by interferon beta treatment in MS.
    Zang YC; Yang D; Hong J; Tejada-Simon MV; Rivera VM; Zhang JZ
    Neurology; 2000 Aug; 55(3):397-404. PubMed ID: 10932275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients.
    Fukaura H; Kent SC; Pietrusewicz MJ; Khoury SJ; Weiner HL; Hafler DA
    J Clin Invest; 1996 Jul; 98(1):70-7. PubMed ID: 8690806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.